1. Ball А. P., Davey P. G., Gedden А. М. et al. Clavulanic acid and amoxicillin: a clinical, bacteriological and pharmacological study // Lancet.- 1980.- Vol. 1.- P. 620-623.
2. Barry A. L., Jones R. N. Bacterial Antibiotic Resistance Before and After Clinical Application in the United States // Bull. N. Y. Acad. Med .- 1987.- Vol. 63.- P. 217-230.
3. Brogden R.N., Carmine A ., Heel R. C. et al. Amoxicillin / clavulanic acid: a review of its antibacterial activity, pharmacokinetics and therapeutic use / / Drugs.- 1981.- Vol. 22.- P. 337- 362.
4. Hamilton Miller J. М. T. Beta-lactam ases and their Clinical Significance / / J. Antimicrob. Chemother.- 1982.- Vol. 9, Suppl. B.- P. 11 - 19.
5. Meyers B. R. Bacterial Resistance: Exploring the Facts and Myths / / Bull. N. Y. Acad. M e d .- 1987.- Vol. 63.- P. 211- 216.
6. Neu H. C. Penicillins F. / / Principles and Practice of Infectious Diseases / Ed. G. L. Mandell et a l.-' New York: Willey, 1985.- P. 166- 181.
7. Neu H: C., Fu K. P. C lavulanic acid a novel inhibitor of beta-lactam ases / / Antimicorob. Agents. Chemother.- 1987.- Vol. 14.- P. 650-655.
8. Parker R. М., Eggleston M. Beta-lactam ase Inhibitors: Another Approach to overcome Antimicrobial Resistance / / Infect. Control.- 1987.- Vol. 8.- P. 36-40.
9. Reading C., Coole M. C lavulanic acid. A B eta-lactam ase Inhibiting Beta-lactam from Streptomyces clavuligerus / / Antimicrob. Agents. Chem other.- 1977.- Vol. 11.- P. 852-857.
10. Todd P. A., Benfield P. Amoxicillin / Clavulanic Acid. An U pdate of its Antibacterial Activity, Pharmacokinetic Properties and Therapeutic Use 11 D rugs.- 1990.- Vol. 39.- P. 264- 307.
11. Wise R. Beta-lactamase inhibitors 11 J. Antimicrob. Chemother.- 1982.- Vol. 9, Suppl. B.- P. 31- 40.